表紙
市場調查報告書

遠程醫療的全球市場:2019-2030年

Global Telemedicine Market: Analysis and Forecast, 2019-2030

出版商 BIS Research Inc. 商品編碼 955298
出版日期 內容資訊 英文 239 Pages
商品交期: 最快1-2個工作天內
價格
遠程醫療的全球市場:2019-2030年 Global Telemedicine Market: Analysis and Forecast, 2019-2030
出版日期: 2020年08月25日內容資訊: 英文 239 Pages
簡介

全球遠程醫療的市場規模2030年是1230億美元成長。由於降低成本的機會,許多健康保險、醫療保險的適用化等要素,遠程醫療的需求大幅度擴大。還有在新型冠狀病毒感染疾病 (COVID-19)的全球性流行下,遠程醫療服務成為對醫療部門來說重要的資產。

本報告提供全球遠程醫療的市場調查,市場定義和概要,COVID-19以及其他的市場影響因素分析,資金籌措、償付、規定方案,經營模式、價格分析,相關法律,市場規模的變化、預測,零組件、技術、診療科、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

摘要整理

第1章 產品定義

第2章 調查範圍

第3章 調查手法

第4章 產業分析

  • 遠程醫療的演進
  • 遠程醫療的必要性:醫療行為的變化相關見解
  • 改變醫療的習慣的遠程醫療
  • 遠程醫療的引進等級:COVID-19前後的比較
  • 競爭環境
  • 資金籌措方案
  • 償付、規定方案

第5章 新的經營模式、價格分析

  • 經營模式、收益途徑分析
  • 成本分析
    • 硬體設備
    • 軟體
    • 遠隔協商服務
  • 消費者支出分析
  • 應對力:各地區

第6章 法律規範:各地區

第7章 市場動態

  • 市場成長要素
  • 阻礙市場要素
  • 市場機會

第8章 競爭情形

  • 近幾年主要的展開
  • 市場佔有率分析

第9章 市場分析、預測:各元件類型

  • 硬體設備
  • 軟體
  • 服務

第10章 市場分析、預測:各技術

  • 即時視訊
  • 遙控病患監測(RPM)
  • 儲存後轉送
  • 其他

第11章 市場分析、預測:各診療科

  • 放射線
  • 心臟血管
  • 病理
  • ICU
  • 精神科
  • 皮膚科
  • 其他
    • 中風
    • 內分泌系
    • 婦產科
    • 眼科
    • 腎臟

第12章 市場分析、預測:各部署模式

  • 雲端
  • 內部部署

第13章 市場分析、預測:各類型

  • 醫院遠程醫療
  • 家庭遠程醫療

第14章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 西班牙
    • 義大利
    • 德國
    • 法國
    • 荷蘭
    • 波蘭
    • 瑞典
    • 丹麥
    • 其他
  • 亞太地區
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 中國
    • 其他
  • 其他地區
    • 巴西
    • 墨西哥
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 俄羅斯
    • 其他

第15章 企業簡介

  • Allscripts Healthcare Solutions, Inc.
  • AMD Global Telemedicine, Inc.
  • American Well
  • Cisco Systems, Inc.
  • Crossover Health, Inc.
  • Doctor On Demand
  • General Electric Company (GE)
  • iCliniq
  • Intel Corporation
  • International Business Machines Corporation (IBM)
  • Koninklijke Philips N.V.
  • MDLIVE, Inc.
  • Poly
  • Teladoc Health Inc.
  • VirTrial Inc.
目錄
Product Code: BHD0962SA

Global Telemedicine Market to Reach $123.0 Billion by 2030

Market Report Coverage - Telemedicine

Market Segmentation

  • Component - Hardware, Software and Services
  • Application - Teleradiology, Telecardiology, Telepathology, Tele-ICU, Telepsychiatry, Teledermatology, Others
  • Mode of Delivery - Cloud based, and On-Premise
  • Type - Tele-hospitals/Clinics, and Tele-homes

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, France, Italy, U.K., Spain, Poland, Sweden, Netherlands, Denmark, Rest-of-Europe
  • Asia-Pacific - Japan, China, India, South Korea, Australia, Rest-of-Asia-Pacific
  • Rest-of-the-World - Kingdom of Saudi Arabia (K.S.A.), Israel, Brazil, Mexico, United Arab Emirates, South Africa, Russia, Rest-of-RoW

Growth Drivers

  • Surge in population and need to expand healthcare access
  • Rising prevalence of chronic conditions and cost-benefits of telehealth & telemedicine
  • Shortage of physicians
  • Advancements in telecommunication technology
  • Government support and rising awareness

Market Challenges

  • Reimbursement framework
  • Lack of integration
  • Lack of sufficient data for care continuity
  • Awareness related to services
  • Lack of technical skills among patients

Market Opportunities

  • Providing frontline care
  • Remote monitoring of compliance with treatment plans and medication
  • Behavioral health telemedicine consultations

Key Telemedicine Companies Profiled

Teladoc Health Inc., Doctor On Demand, MDLIVE, Inc., American Well, Virtrial Inc., AMD Global Telemedicine, Inc., Poly, Koninklijke Philips N.V, General Electric Company (GE), International Business Machines Corporation (IBM), Crossover Health, Inc., Allscripts Healthcare Solutions, Inc., Cisco Systems, Inc., and Intel Corporation, among others.

Key Questions Answered in this Report:

  • How has the market evolved in the last five years, and what are the awaited technological advancements in the field of telemedicine?
  • What are the major market drivers, challenges, and opportunities in the global telemedicine market?
  • What are the underlying structures resulting in the emerging trends within the telemedicine industry?
  • What was the market value of the leading segments of the global telemedicine market in 2019?
  • What are the influencing factors that may affect the market share of the key players?
  • How is industry expected to evolve during the forecast period 2019-2030?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What is the current market share of each of the companies in the global telemedicine market and what are expected to be their contributions in 2030?
  • What is the growth potential of telemedicine in each region, including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World?
  • What are the key regulatory implications in developed and developing regions for telemedicine?
  • What was the average number of tele-consultations, pricing, and reimbursement scenario (if any) by country, in 2019?

Market Overview

Telemedicine is a powerful tool that makes healthcare accessible, cost-effective, and significantly enhances patient engagement. The debut of telemedicine dates back to late 1950s and has constantly evolved over the years with advancements in the field of tele-communication technology. The application of telemedicine is enormous. It enables physicians and patients to share real time health-related information from one computer screen to another. With the help of a telemedicine software, patients can connect with a doctor at the comfort of their home for diagnosis as well as treatment without needing an appointment.

The demand for telemedicine has significantly increased due to the cost savings opportunity offered by the technology. It also reduces the need for patients to visit an emergency room and the costs associated with the same. As per a study published in healthaffairs.org (2017), the average cost of telemedicine visit is $79 while the average doctor's visit is $149 and the average trip to the emergency room is $1,734.

As the demand and popularity for telemedicine grows, many health insurance plans are also starting to provide coverage for tele-consultations. In the U.S., many states such as Arkansas, Delaware, Georgia, and Hawaii, have laws established that require health insurance plans to reimburse remotely delivered care at the same rate as in-person doctor visits.

With the ongoing COVID-19 pandemic, telemedicine services have become a critical asset for the healthcare community. The telemedicine services can provide efficient delivery of care especially for populations and patients affected by the COVID-19 infection, especially when under active quarantine. Under these critical times, these services can significantly help healthcare systems to reduce resource usage across the stressed health-care infrastructure, ameliorates access to care, and reduces the risk of direct person-to-person transmission of the infectious agent.

The current telemedicine market is strongly fuelled by the fears related to coronavirus and staggering shifts in payment rules. To further boost the demand, many health insurers have also come forward. For example, in February, Aetna, a leading health insurance provider waived its $45 patient co-payment for virtual care. In 3rd week of March, Medicare also allowed its enrolled customers to use telemedicine. This option was previously available to only people living in remote areas. The demand surge can also be understood from the fact that Cleveland Clinic, a leading health system in the U.S., logged more than 60,000 telemedicine visits in March, while prior to the month, the health system registered only 3,400 visits a month.

Within the research report, the market is segmented on the basis of component type, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

In the global telemedicine market, the revenue is majorly generated by four key participants: telemedicine software providers, remote patient monitoring device manufacturers, infrastructure and connectivity providers, and telemedicine service providers.

As of 2019, the telemedicine software companies (including RPM software and health IT infrastructure providers) generated a revenue of $7.07 billion while remote patient monitoring device manufacturers generated a revenue of $5.94 billion followed by infrastructure and connectivity providers ($5.26 billion) and telemedicine service providers ($1.78 billion).

In the hardware segment some of the major companies include Masimo, Medtronic, and GE Healthcare, accounting for 15.75%, 14.04%, and 13.46% of the overall market, respectively.

Among the software providers, Microsoft held the largest share in the global telemedicine market accounting for 33.50% of the overall market, followed by IBM and Allscripts, accounting for 25.45%, and 22.34% of the market, respectively.

From a service provider perspective, Ping A Good Doctor was the global leader in the telemedicine services market accounting for 40.10% of the overall market in 2019. This is followed by Teladoc and Amwell, accounting for 31.00% and 11.60% of the global telemedicine services market, respectively.

Additionally, several start-ups emerged to provide telehealth consultations globally, such as 98point6, Vida Health, Medici, Healthtap, Maven Clinic, Doctor Anywhere, Zipnosis, SnapMD, Cloudbreak Health, Cloud DX, Maple, TeleClinic, and Genome Medical.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Scope of the Study

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Companies Profiled
  • 3.5 Assumptions and Limitations

4 Industry Analysis

  • 4.1 Evolution of Telemedicine
  • 4.2 Need for Telemedicine: A View of Changing Medical Practices
  • 4.3 Telemedicine Changing Medical Practices
  • 4.4 Level of Telemedicine Adoption from a Pre-and Post-COVID-19 Perspective
    • 4.4.1 Pre-COVID Scenario
    • 4.4.2 During COVID-19 Scenario
    • 4.4.3 Post-COVID-19 Scenario
  • 4.5 Competitive Landscape: Existing and New Entrant Competition Analysis
  • 4.6 Funding Scenario
  • 4.7 Reimbursement and Regulatory Scenario

5 New Business Model and Pricing Analysis

  • 5.1 Business Model and Revenue Channel Analysis (for New Entrants and Existing Players)
  • 5.2 Cost Analysis (in Terms of Infrastructure such as (Hardware/Software/ Services)
    • 5.2.1 Hardware
    • 5.2.2 Software
    • 5.2.3 Teleconsultation Services
  • 5.3 Consumer Spending Analysis
  • 5.4 Readiness of Geographies (in Terms of Digital Infrastructure)

6 Regulatory Framework

  • 6.1 North America
    • 6.1.1 U.S.
    • 6.1.2 Canada
  • 6.2 Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 Spain
    • 6.2.5 U.K.
  • 6.3 Asia-Pacific
    • 6.3.1 India
    • 6.3.2 China
    • 6.3.3 South Korea
    • 6.3.4 Japan

7 Market Dynamics

  • 7.1 Market Drivers
    • 7.1.1 Increase in Patient Demand for Virtually Delivered Care
    • 7.1.2 Increased Reimbursement for Remote Care Services
    • 7.1.3 Urgent Need to Reduce the Cost of Care
    • 7.1.4 Increasing Regulatory Approval
  • 7.2 Market Restraints
    • 7.2.1 Reluctance by Physicians
    • 7.2.2 Lack of ICT (Information and Communications Technology) Infrastructure in Rural Areas
    • 7.2.3 Data Privacy
  • 7.3 Market Opportunities
    • 7.3.1 Accelerated Growth in the Post-COVID-19 World
    • 7.3.2 Increase in Funding for the Telehealth Start-Up Ecosystem
    • 7.3.3 Remote Monitoring

8 Competitive Landscape

  • 8.1 Recent Key Developments
    • 8.1.1 Product Launches
    • 8.1.2 Collaborations and Partnerships
    • 8.1.3 Mergers and Acquisitions
    • 8.1.4 Funding
    • 8.1.5 Joint Ventures
  • 8.2 Market Share Analysis

9 Global Telemedicine Market (by Component Type)

  • 9.1 Hardware
  • 9.2 Software
  • 9.3 Services

10 Global Telemedicine Market (by Technology)

  • 10.1 Real-Time Video
  • 10.2 Remote Patient Monitoring (RPM)
  • 10.3 Store and Forward
  • 10.4 Others

11 Global Telemedicine Market (by Medical Specialty)

  • 11.1 Teleradiology
  • 11.2 Telecardiology
  • 11.3 Telepathology
  • 11.4 Tele-ICU
  • 11.5 Telepsychiatry
  • 11.6 Teledermatology
  • 11.7 Others
    • 11.7.1 Telestroke
    • 11.7.2 Tele-endocrinology
    • 11.7.3 Telegynecology
    • 11.7.4 Teleophthalmology
    • 11.7.5 Telenephrology

12 Global Telemedicine Market (by Mode of Delivery)

  • 12.1 Cloud-Based
  • 12.2 On-Premise

13 Global Telemedicine Market (by Type)

  • 13.1 Tele-Hospitals
  • 13.2 Tele-Home

14 Global Telemedicine Market (by Region)

  • 14.1 North America
    • 14.1.1 U.S.
    • 14.1.2 Canada
  • 14.2 Europe
    • 14.2.1 U.K.
    • 14.2.2 Spain
    • 14.2.3 Italy
    • 14.2.4 Germany
    • 14.2.5 France
    • 14.2.6 Netherlands
    • 14.2.7 Poland
    • 14.2.8 Sweden
    • 14.2.9 Denmark
    • 14.2.10 Rest-of-Europe
  • 14.3 Asia-Pacific
    • 14.3.1 India
    • 14.3.2 South Korea
    • 14.3.3 Japan
    • 14.3.4 Australia
    • 14.3.5 China
    • 14.3.6 Rest-of-Asia-Pacific
  • 14.4 Rest-of-the-World
    • 14.4.1 Brazil
    • 14.4.2 Mexico
    • 14.4.3 Kingdom of Saudi Arabia
    • 14.4.4 United Arab Emirates
    • 14.4.5 Israel
    • 14.4.6 South Africa
    • 14.4.7 Russia
    • 14.4.8 Rest-of-RoW

15 Company Profiles

  • 15.1 Allscripts Healthcare Solutions, Inc.
    • 15.1.1 Company Overview
    • 15.1.2 Role of Allscripts Healthcare Solutions, Inc. in the Global Telemedicine Market
    • 15.1.3 Product Offerings
    • 15.1.4 Recent Developments
    • 15.1.5 Financials
    • 15.1.6 SWOT Analysis
  • 15.2 AMD Global Telemedicine, Inc.
    • 15.2.1 Company Overview
    • 15.2.2 Role of AMD Global Telemedicine, Inc. in the Global Telemedicine Market
    • 15.2.3 Product Offerings
    • 15.2.4 Recent Developments
    • 15.2.5 SWOT Analysis
  • 15.3 American Well
    • 15.3.1 Company Overview
    • 15.3.2 Role of American Well in the Global Telemedicine Market
    • 15.3.3 Product Offerings
    • 15.3.4 Recent Developments
    • 15.3.5 SWOT Analysis
  • 15.4 Cisco Systems, Inc.
    • 15.4.1 Company Overview
    • 15.4.2 Role of Cisco Systems, Inc. in the Global Telemedicine Market
    • 15.4.3 Product Offerings
    • 15.4.4 Recent Developments
    • 15.4.5 Financials
    • 15.4.6 SWOT Analysis
  • 15.5 Crossover Health, Inc.
    • 15.5.1 Company Overview
    • 15.5.2 Role of Crossover Health, Inc. in the Global Telemedicine Market
    • 15.5.3 Product Offerings
    • 15.5.4 Recent Developments
    • 15.5.5 SWOT Analysis
  • 15.6 Doctor On Demand
    • 15.6.1 Company Overview
    • 15.6.2 Role of Doctor On Demand in the Global Telemedicine Market
    • 15.6.3 Product Offerings
    • 15.6.4 Recent Developments
    • 15.6.5 SWOT Analysis
  • 15.7 General Electric Company (GE)
    • 15.7.1 Company Overview
    • 15.7.2 Role of General Electric in the Global Telemedicine Market
    • 15.7.3 Product Offerings
    • 15.7.4 Recent Developments
    • 15.7.5 Financials
    • 15.7.6 SWOT Analysis
  • 15.8 iCliniq
    • 15.8.1 Company Overview
    • 15.8.2 Role of iCliniq in the Global Telemedicine Market
    • 15.8.3 Product Offerings
    • 15.8.4 SWOT Analysis
  • 15.9 Intel Corporation
    • 15.9.1 Company Overview
    • 15.9.2 Role of Intel Corporation in the Global Telemedicine Market
    • 15.9.3 Product Offerings
    • 15.9.4 Recent Developments
    • 15.9.5 Financials
    • 15.9.6 SWOT Analysis
  • 15.1 International Business Machines Corporation (IBM)
    • 15.10.1 Company Overview
    • 15.10.2 Role of IBM in the Global Telemedicine Market
    • 15.10.3 Product Offerings
    • 15.10.4 Recent Developments
    • 15.10.5 Financials
    • 15.10.6 SWOT Analysis
  • 15.11 Koninklijke Philips N.V.
    • 15.11.1 Company Overview
    • 15.11.2 Role of Koninklijke Philips N.V. in the Global Telemedicine Market
    • 15.11.3 Product Offerings
    • 15.11.4 Recent Developments
    • 15.11.5 Financials
    • 15.11.6 SWOT Analysis
  • 15.12 MDLIVE, Inc.
    • 15.12.1 Company Overview
    • 15.12.2 Role of MDLIVE, Inc. in the Global Telemedicine Market
    • 15.12.3 Product Offerings
    • 15.12.4 Recent Developments
    • 15.12.5 SWOT Analysis
  • 15.13 Poly
    • 15.13.1 Company Overview
    • 15.13.2 Role of Poly in the Global Telemedicine Market
    • 15.13.3 Product Offerings
    • 15.13.4 Recent Developments
    • 15.13.5 Financials
    • 15.13.6 SWOT Analysis
  • 15.14 Teladoc Health Inc.
    • 15.14.1 Company Overview
    • 15.14.2 Role of Teladoc Health, Inc. in the Global Telemedicine Market
    • 15.14.3 Product Offerings
    • 15.14.4 Recent Developments
    • 15.14.5 Financials
    • 15.14.6 SWOT Analysis
  • 15.15 VirTrial Inc.
    • 15.15.1 Company Overview
    • 15.15.2 Role of VirTrial Inc. in the Global Telemedicine Market
    • 15.15.3 Product Offerings
    • 15.15.4 Recent Developments
    • 15.15.5 SWOT Analysis

List of Tables

  • Table 4.1: Timeline for Telemedicine Development
  • Table 4.2: Change in Adoption of Telemedicine in Different Medical Specialties (Pre-COVID Scenario)
  • Table 4.3: Change in Adoption of Telemedicine in Different Medical Specialties (During COVID-19)
  • Table 4.4: Snapshot of Key Participants in the Telemedicine Market
  • Table 4.5: U.S. Hospitals with the Highest Funding from FCC's COVID-19 Telehealth Program
  • Table 4.6: Recent Funding Rounds Pertaining to the Telemedicine Market
  • Table 5.1: A Comparison of Nine Successful Business Models from Diverse Geographic Regions and Revenue Streams
  • Table 5.2: Hardware Cost Analysis: Global Telemedicine Market
  • Table 5.3: Software Cost Analysis: Global Telemedicine Market
  • Table 5.4: Teleconsultation Cost Analysis: Global Telemedicine Market
  • Table 5.5: Global Infrastructure for Telemedicine
  • Table 6.1: Telemedicine Regulations Followed by States in the U.S.
  • Table 6.2: Telemedicine Regulations Followed by Province/Territory in Canada
  • Table 9.1: Major Hardware Components Used in Telemedicine Programs
  • Table 9.2: Leading Commercially Available Telemedicine Software and their Providers
  • Table 9.3: Leading Telemedicine Service Providers in the Market
  • Table 12.1: Telemedicine Software Providers offering Cloud solutions/ Cloud and On-Premise Solutions to Healthcare Providers:

List of Figures

  • Figure 1: Increase in Number of Telehealth Users in the U.S. (2013 and 2018)
  • Figure 2: Use of Telehealth in the U.S. Hospitals (2010-2017)
  • Figure 3: Global Challenges Inhibiting the Market Growth
  • Figure 4: Key Opportunities in the Global Telemedicine Market
  • Figure 5: Global Telemedicine Market, $Billion, 2019-2030
  • Figure 6: Global Telemedicine Market (by Component Type), $Billion, 2019 and 2030
  • Figure 7: Global Telemedicine Market (by Hardware Type), $Billion, 2019, 2025, and 2030
  • Figure 8: Global Telemedicine Market (by Type/Service Delivery Model), $Billion, 2019, 2025, and 2030
  • Figure 9: Global Telemedicine Market (by Medical Specialty), $Billion, 2019 and 2030
  • Figure 10: Global Telemedicine Market (Mode of Delivery), $Billion, 2019-2030
  • Figure 11: Global Telemedicine Market (by Type), $Billion, 2019-2030
  • Figure 12: Global Telemedicine Market (by Region), $Billion, 2019 and 2030
  • Figure 2.1: Global Telemedicine Market Segmentation
  • Figure 3.1: Global Telemedicine Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: The Decline in Number of Visits to Ambulatory Practices (Percentage)
  • Figure 4.2: A Comparison of Decline in Number of In-Person Visits and All Types of Visits (Telemedicine and In-Person Visits)
  • Figure 4.3: Number of Telehealth Visits in a Given Week as a Percent of Baseline Total Visits
  • Figure 4.4: Number of Telehealth Visits in a Given Week, by Medical Specialty
  • Figure 4.5: Niche Players in the Global Telemedicine Services Market
  • Figure 4.6: Global Overall Competitive Ecosystem (Including Hardware + Software)
  • Figure 8.1: Share of Key Developments and Strategies (N = 268)
  • Figure 8.2: Market Share Analysis for RPM Device Manufacturers in the Telemedicine Market
  • Figure 8.3: Market Share Analysis for Software Providers in the Telemedicine Market
  • Figure 8.4: Market Share Analysis for Service Providers in the Telemedicine Market
  • Figure 9.1: Illustration of Global Telemedicine Market Components
  • Figure 9.2: Global Telemedicine Market Share (by Component Type) in 2019
  • Figure 9.3: Global Telemedicine Hardware Market, $Billion, 2019-2030
  • Figure 9.4: Global Telemedicine Software Market, $Billion, 2019-2030
  • Figure 9.5: Global Telemedicine Services Market, $Billion, 2019-2030
  • Figure 10.1: Global Telemedicine Market (by Technology)
  • Figure 10.2: Global Real-Time Telemedicine Market, $Billion, 2019-2030
  • Figure 10.3: Global Remote Monitoring Telemedicine Market, $Billion, 2019-2030
  • Figure 10.4: Global Store and Forward Telemedicine Market, $Billion, 2019-2030
  • Figure 10.5: Others Telemedicine Type Market, $Billion, 2019-2030
  • Figure 11.1: Global Teleradiology Market, $Billion, 2019-2030
  • Figure 11.2: Impact of Market Drivers and Market Restraints
  • Figure 11.3: Global Telecardiology Market, $Billion, 2019-2030
  • Figure 11.4: Global Telepathology Market, $Billion, 2019-2030
  • Figure 11.5: Global TeleICU Market, $Billion, 2019-2030
  • Figure 11.6: Global Telepsychiatry Market, $Billion, 2019-2030
  • Figure 11.7: Global Teledermatology Market, $Billion, 2019-2030
  • Figure 11.8: Other Medical Specialty Market, $Billion, 2019-2030
  • Figure 12.1: Global Cloud Based Telemedicine Solutions, $Billion, 2019-2030
  • Figure 12.2: Global On-Premise Telemedicine Solutions, $Billion, 2019-2030
  • Figure 13.1: Global Tele-Hospitals/Teleclinics Market, $Billion, 2019-2030
  • Figure 13.2: Global Telehome Market, $Billion, 2019-2030
  • Figure 14.1: North America Telemedicine Market, $Billion, 2019-2030
  • Figure 14.2: U.S. Telemedicine Market, $Billion, 2019-2030
  • Figure 14.3: Canada Telemedicine Market, $Billion, 2019-2030
  • Figure 14.4: Europe Telemedicine Market, $Billion, 2019-2030
  • Figure 14.5: U.K. Telemedicine Market, $Billion, 2019-2030
  • Figure 14.6: Spain Telemedicine Market, $Billion, 2019-2030
  • Figure 14.7: Italy Telemedicine Market, $Billion, 2019-2030
  • Figure 14.8: Germany Telemedicine Market, $Billion, 2019-2030
  • Figure 14.9: France Telemedicine Market, $Billion, 2019-2030
  • Figure 14.10: Netherlands Telemedicine Market, $Billion, 2019-2030
  • Figure 14.11: Poland Telemedicine Market, $Billion, 2019-2030
  • Figure 14.12: Sweden Telemedicine Market, $Billion, 2019-2030
  • Figure 14.13: Denmark Telemedicine Market, $Billion, 2019-2030
  • Figure 14.14: Rest-of-Europe Telemedicine Market, $Billion, 2019-2030
  • Figure 14.15: Asia-Pacific Telemedicine Market, $Billion, 2019-2030
  • Figure 14.16: India Telemedicine Market, $Billion, 2019-2030
  • Figure 14.17: Japan Telemedicine Market, $Billion, 2019-2030
  • Figure 14.18: Australia Telemedicine Market, $Billion, 2019-2030
  • Figure 14.19: China Telemedicine Market, $Billion, 2019-2030
  • Figure 14.20: Rest-of-Asia-Pacific Telemedicine Market, $Billion, 2019-2030
  • Figure 14.21: Rest-of-the-World Telemedicine Market, $Billion, 2019-2030
  • Figure 14.22: Brazil Telemedicine Market, $Billion, 2019-2030
  • Figure 14.23: Mexico Telemedicine Market, $Billion, 2019-2030
  • Figure 14.24: Saudi Arabia Telemedicine Market, $Billion, 2019-2030
  • Figure 14.25: U.A.E Telemedicine Market, $Billion, 2019-2030
  • Figure 14.26: Israel Telemedicine Market, $Billion, 2019-2030
  • Figure 14.27: South Africa Telemedicine Market, $Billion, 2019-2030
  • Figure 14.28: Rest-of-RoW Telemedicine Market, $Billion, 2019-2030
  • Figure 15.1: Allscripts Healthcare Solutions, Inc.: Telemedicine Offerings
  • Figure 15.2: Allscripts Healthcare Solutions, Inc.: Overall Financials, 2017-2019
  • Figure 15.3: Allscripts Healthcare Solutions, Inc.: Revenue (by Segment), 2017-2019
  • Figure 15.4: Allscripts Healthcare Solutions, Inc.: Revenue (by Region), 2017-2019
  • Figure 15.5: Allscripts Healthcare Solutions, Inc.: SWOT Analysis
  • Figure 15.6: AMD Global Telemedicine, Inc.: SWOT Analysis
  • Figure 15.7: American Well: SWOT Analysis
  • Figure 15.8: Cisco Systems, Inc.: Overall Financials, 2017-2019
  • Figure 15.9: Cisco Systems, Inc.: Revenue (by Segment), 2017-2019
  • Figure 15.10: Cisco Systems, Inc.: Revenue (by Region), 2017-2019
  • Figure 15.11: Cisco Systems, Inc.: SWOT Analysis
  • Figure 15.12: Crossover Health, Inc.: SWOT Analysis
  • Figure 15.13: Doctor On Demand: SWOT Analysis
  • Figure 15.14: GE: Overall Financials, 2017-2019
  • Figure 15.15: GE.: Revenue (by Segment), 2017-2019
  • Figure 15.16: GE.: Revenue (by Sub-Segment), 2017-2019
  • Figure 15.17: GE.: Revenue (by Region), 2017-2019
  • Figure 15.18: General Electric Company: SWOT Analysis
  • Figure 15.19: iCliniq: SWOT Analysis
  • Figure 15.20: Intel Corporation: Telemedicine Offerings
  • Figure 15.21: Intel Corporation: Overall Financials, 2017-2019
  • Figure 15.22: Intel Corporation: Revenue (by Segment), 2017-2019
  • Figure 15.23: Intel Corporation: Revenue (by Region), 2017-2019
  • Figure 15.24: Intel Corporation: SWOT Analysis
  • Figure 15.25: IBM: Overall Financials, 2017-2019
  • Figure 15.26: IBM: Revenue (by Segment), 2017-2019
  • Figure 15.27: IBM: Revenue (by Region), 2017-2019
  • Figure 15.28: International Business Machines (IBM): SWOT Analysis
  • Figure 15.29: Koninklijke Philips N.V.: Overall Financials, 2016-2019
  • Figure 15.30: Koninklijke Philips N.V.: Revenue (by Segment), 2016-2019
  • Figure 15.31: Koninklijke Philips N.V.: Revenue (by Region), 2016-2019
  • Figure 15.32: Koninklijke Philips N.V.: SWOT Analysis
  • Figure 15.33: MDLIVE, Inc.: SWOT Analysis
  • Figure 15.34: Poly: Overall Financials, 2017-2019
  • Figure 15.35: Poly: Revenue (by Segment), 2017-2019
  • Figure 15.36: Poly: Revenue (by Region), 2017-2019
  • Figure 15.37: Poly: SWOT Analysis
  • Figure 15.38: Teladoc Health: Overall Financials, 2016-2019
  • Figure 15.39: Teladoc Health, Inc.: SWOT Analysis
  • Figure 15.40: VirTrial Inc.: SWOT Analysis